Value-Based Care: A Strategic Imperative for Women’s Cancer Treatment
By Marketing
Staff Writer
January 21, 2026 in Patient-centric Care
The landscape of women’s cancers in the United States presents a complex challenge that demands innovative approaches to care delivery. While breast cancer incidence continues to rise in certain populations, cervical cancer is showing concerning increases among younger patients and in advanced-stage presentations. The burden of these diseases falls disproportionately along socioeconomic lines, underscoring the need for care models that address both clinical and social factors.
The Impact of Social Determinants of Health
Social determinants of health (SDOH) play a significant role in cancer outcomes. Recent research shows that women living in the most socioeconomically deprived neighborhoods face a substantially higher mortality rates from breast cancer compared to those in the least deprived areas. These disparities extend beyond breast cancer to head and neck cancers, gastrointestinal malignancies, and other common cancer types, making it clear that social context fundamentally shapes outcomes.
The challenge is stark: Rising breast cancer incidence is more frequently detected among women with higher socioeconomic status and better access to screening, while late-stage and aggressive disease disproportionately affects socioeconomically disadvantaged and racially marginalized populations. In cervical cancer, SDOH often determine whether women benefit from routine screening and vaccination or face limited access due to geography, employment constraints, or lack of transportation. Even when screening occurs in underserved populations, rates of advanced-stage disease remain unacceptably high compared to those with fewer barriers to care.
Building Effective Value-Based Care Models
Value-based care represents a fundamental shift from traditional fee-for-service medicine to models that reward quality outcomes and cost efficiency. According to 2023 data, approximately a majority of health care payments are now linked to quality or value initiatives, including pay-for-performance, shared savings, and population-based arrangements.
For oncology practices, federal programs such as Principal Care Management (PCM) offer structured pathways to value-based care. PCM covers Medicare services for managing a single complex, high-risk chronic condition using specific CPT codes to bill for monthly physician and clinical staff time. This model supports proactive, specialized care for patients with cancer who are at increased risk for hospitalization, functional decline, or mortality.
Beyond federal initiatives, innovative partnerships are reshaping oncology payment models. Evolent Health and American Oncology Network are developing an aligned payment approach that rewards high-quality care while seeking to reduce unnecessary administrative burden. This model supports clinical decision-making through quality-focused interventions, advanced data analytics, and a “gold-card” framework in which providers who consistently demonstrate adherence to evidence-based guidelinesmay qualify for streamlined authorization processes, subject to payer policies.
Driving Better Outcomes Through Data and Collaboration
Effective value-based care depends on sophisticated data interoperability and real-time analytics. Integrating socioeconomic measures such as the Area Deprivation Index (ADI) into clinical operations allows practices to identify patient barriers to care, including transportation challenges, food insecurity, housing instability, and limited health literacy. These social determinants directly contribute to operational challenges such as missed appointments, delayed diagnoses, avoidable hospitalizations, and higher patient acuity at presentation.
AON has embedded ADI across multiple departments, from clinical care to finance, using these insights to inform payer contract modeling, rate negotiations, value-based strategy development, and practice performance benchmarking. These efforts are intended to support more informed decision-making across the organization.
The Path Forward: Collaboration and Scale
Managing the growing complexity of cancer care requires strong collaboration among payers, providers, and health systems. Successful value-based models combine provider education, real-time performance scorecards, automated reminders within electronic medical records, and aligned incentives that support clinically appropriate treatment selection for each patient.
Scalable solutions that reduce disparities and expand access to comprehensive women’s cancer care are no longer optional. Through programs like AON’s American Oncology Cares, practices can offer transportation support, food resources, and community health navigation to help address barriers to care, consistent with applicable patient assistance guidelines. By leveraging shared expertise and scale, oncology networks can help practices operationalize value-based care through clear communication, coordinated services, and cohesive patient management—ultimately delivering better outcomes for all women facing a cancer diagnosis.
Ensuring that where a person lives does not determine whether they live is a responsibility the health care system must collectively embrace.
Join the Conversation
Corporate Office
14543 Global Parkway
Suite 110
Fort Myers, FL 33913
Celebrating The History of Female Physicians